NICOLETTE NETZ: Open Payments
NPI 1588338115 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,549 in 62 payments from 15 companies in 2025. Trend: 2023 $2,169 · 2024 $1,625 · 2025 $1,549
Food & beverage: $1,549
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $351 |
| Lilly USA, LLC | 16 | $158 |
| LEO Pharma Inc. | 8 | $146 |
| Arcutis Biotherapeutics, Inc. | 8 | $136 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $129 |
| Galderma Laboratories, L.P. | 5 | $111 |
| Incyte Corporation | 2 | $95 |
| UCB, Inc. | 2 | $71 |
| Regeneron Healthcare Solutions, Inc. | 1 | $70 |
| Amgen Inc. | 3 | $64 |
Products named: TALTZ, Zoryve, NEMLUVIO, OPZELURA, DUPIXENT, ANZUPGO, Bimzelx, ADBRY.
Industry payments across NE — which companies pay providers there.
